2.High-Dose Cytosine Arabinoside (HD Ara-C) Therapy for Refractory Acute Leukemia in Children.
Il Soo HA ; Hyo Seop AHN ; Chang Yee HONG
Journal of the Korean Pediatric Society 1988;31(10):1328-1337
No abstract available.
Child*
;
Cytarabine*
;
Cytosine*
;
Humans
;
Leukemia*
3.Intrapleural chemotherapy with cisplatin and cytarabine in the management of malignant pleural effusion.
Korean Journal of Medicine 2000;58(2):250-252
No abstract available.
Cisplatin*
;
Cytarabine*
;
Drug Therapy*
;
Pleural Effusion, Malignant*
4.The Effect of Subconjunctival Injection of Liposome Encapsulated Cytarabine on Proliferation of Fibroblasts.
Gong Je SEONG ; Young Jae HONG ; Seong Jun PARK
Journal of the Korean Ophthalmological Society 1992;33(9):885-891
To know the effect of subconjunctival injection of liposome encapsulated cytarabine on proliferation of conjunctival fibroblasts, the conjunctiva was isolated at 180 degrees from the injection site 3 days after subconjunctival injection of the normal saline (control), cytarabine, liposome encapsulated cytarabine, and 1 day after injection of cytarabine, and then those were inoculated in the culture media of fibroblasts. In the case of 3 days after injection of cytarabine, there was 49% and 42% inhibition of proliferation of conjunctival fibroblasts compared with the control respectively. Therefore, the authors concluded that the liposome encapsulated cytarabine is effective on inhibition of proliferation of conjunctival fibroblasts and reduces the frequencies of subconjunctival injection compared with the cytarabine itself.
Conjunctiva
;
Culture Media
;
Cytarabine*
;
Fibroblasts*
;
Liposomes*
5.Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma.
Min Seok CHO ; Jae Yong KIM ; Seung Yeon JUNG ; Seo Yeon AHN ; Ga young SONG ; Deok Hwan YANG
Blood Research 2016;51(4):285-287
No abstract available.
Bendamustine Hydrochloride*
;
Cytarabine*
;
Drug Therapy*
;
Lymphoma*
6.Treatment of myelodysplasia syndrome
Journal of Medical and Pharmaceutical Information 2003;0(5):16-22
Myelodysplasia syndrome is a diseases group of which quite
difficult cure and prediction. There are many treatment methods however it depends on patient’s age, level of diease, rate of blast in bone marrow. The treatment includes: chemical treatment, trasplant originative cell, support treatment. Other method is combination of various treatment methods: Use Ara-C combine with depersolon, chemical treatment combine with stimulative agent of blood and trasplant originative cell
Neural Tube Defects
;
Bone Marrow
;
Cytarabine
;
Therapeutics
7.Mitoxantrone and cytosine arabinoside in adult patients with refractory and relapsed acute leukemia.
Jae Yong LEE ; Hyun Choon SHIN ; Young Suk PARK ; Jung Soon JANG ; Young Hyuck IM ; Sung Soo YOON ; Seoun Yang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Korean Journal of Hematology 1993;28(2):257-265
No abstract available.
Adult*
;
Cytarabine*
;
Cytosine*
;
Humans
;
Leukemia*
;
Mitoxantrone*
8.Combination chemotherapy with TAD(6-thioguanine, Ara-C and daunorubicin) in acute myelogenous leukemia.
Hong Seok AHN ; Yong Cheol LEE ; Chang Hun PARK ; Chang Yeol YIM
Korean Journal of Hematology 1991;26(1):73-80
No abstract available.
Cytarabine*
;
Drug Therapy, Combination*
;
Leukemia, Myeloid, Acute*
9.Combination chemotherapy with cytosine arabinoside and idarubicin for acute myelogenous leukemia.
Hyun Choon SHIN ; Chul Won JUNG ; Jin Hak LEE ; Jung Ae LEE ; Sung Hyun YANG ; Young Hyuk LEEM ; Seon Yang PARK ; Byoung Kook KIM ; Noe Kyoung KIM
Korean Journal of Hematology 1993;28(2):247-255
No abstract available.
Cytarabine*
;
Cytosine*
;
Drug Therapy, Combination*
;
Idarubicin*
;
Leukemia, Myeloid, Acute*
10.Renission induction chemotherapy with idarubicin and cytosine arabinoside for the patients with acute myelogenous leukemia.
Jong Youl JIN ; Hyun Suk UHM ; Doo Soo JEON ; Jong Wook LEE ; Chi Hwa HAN ; Woo Sung MIN ; Chong Won PARK ; Chun Choo KIM ; Dong Jip KIM ; Woo Kun CHOI ; Hack Ki KIM
Korean Journal of Hematology 1991;26(2):281-287
No abstract available.
Cytarabine*
;
Cytosine*
;
Humans
;
Idarubicin*
;
Induction Chemotherapy*
;
Leukemia, Myeloid, Acute*
Result Analysis
Print
Save
E-mail